Production of Il-10 and Il-12 in Cd40 and Interleukin 4-Activated Mononuclear Cells from Patients with Graves'disease

By Itoh M.   Uchimura K.   Makino M.   Kobayashi T.   Hayashi R.   Nagata M.   Kakizawa H.   Fujiwara K.   Nagasaka A.  

Cytokine, Vol. 12, Iss. 6, 2000-06 ,pp. : 688-693

Academic Press

Access to resources Recommend Favorite

Reduction in Serum Il-6 After Vacination of Breast Cancer Patients with Tumour-Associated Antigens Is Related to Estrogen Receptor Status

By Jiang X.P.   Yang D.C.   Elliott R.L.   Head J.F.  

Cytokine, Vol. 12, Iss. 5, 2000-05 ,pp. : 458-465

Academic Press

Access to resources Recommend Favorite

Interleukin 2 Pseudomonas Exotoxin (IL2-PE66 4Glu ) Chimeric Protein Kills B Cells from Patients with Myasthenia Gravis

By Steinberger I.   Brenner T.   Lorberboum-Galski H.  

Cellular Immunology, Vol. 169, Iss. 1, 1996-04 ,pp. : 55-61

Academic Press

Access to resources Recommend Favorite

Modulation of Cytokine Release from Mononuclear Cells by Prostacyclin, Il-4 and Il-13

By Luttmann W.   Herzog V.   Matthys H.   Thierauch K-H.   Virchow J.C.   Kroegel C.  

Cytokine, Vol. 11, Iss. 2, 1999-02 ,pp. : 127-133

Academic Press

Access to resources Recommend Favorite

SHORT-TERM TREATMENT OF RELAPSING REMITTING MULTIPLE SCLEROSIS PATIENTS WITH INTERFERON (IFN)-β1B TRANSIENTLY INCREASES THE BLOOD LEVELS OF INTERLEUKIN (IL)-6, IL-10 AND IFN-γ WITHOUT SIGNIFICANTLY MODIFYING THOSE OF IL-1β, IL-2, IL-4 AND TUMOUR NECROSIS FACTOR-α

By Nicoletti F.   Di Marco R.   Patti F.   Zaccone P.   L'Episcopo M.R.   Reggio E.   Xiang M.   Nicoletti A.   Reggio A.  

Cytokine, Vol. 12, Iss. 6, 2000-06 ,pp. : 682-687

Academic Press

Access to resources Recommend Favorite